News


August 13, 2024

Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying

Inhalation drug delivery continues to evolve and develop for the delivery of novel compounds. In a recent publication,...
August 8, 2024

Lovelace and Gilead Discovery of GS-7682

RSV continues to be a focus area within respiratory health with the release of new vaccines and therapeutics. ...
May 2, 2024

Philip Kuehl Co-Authors Article in the Journal of Aerosol Medicine and Pulmonary Drug Delivery

Lovelace Biomedical has an over 70-year history in the area of respiratory drug delivery.  Throughout this history, the...
December 21, 2023

Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium

Pandemic uncertainties cloud nebulizer use. But the COPD Foundation’s CNC offers science-backed guidance to minimize aerosol risks in...
December 19, 2023

Evolving with the FDA Modernization Act

The appropriate utilization of animals within non-clinical research is always on the minds of drug developers. Lovelace Biomedical...
October 9, 2023

2023 Willi Stahlhofen awarded to Lovelace Biomedical’s Scientist Conor Ruzycki as a co-author

The Willi Stahlhofen Award is given to a high impact manuscript in the Journal of Aerosol Medicine and...
September 21, 2023

Inhalation delivery of nucleic acid gene therapies in preclinical drug development

Inhaled gene therapies hold great promise in treating a number of diseases including cystic fibrosis and certain cancers...
June 14, 2023

Lovelace Biomedical Wins 10M to Combat Opioid Overdose

Lovelace Biomedical has recently received 3 new grants and contracts worth over 10 million granted by the National...
June 1, 2023

Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference in Atlanta

Within drug development, the quantitation of drug levels within the systemic circulation and target tissues can provide insight...
February 17, 2023

Promising Toxicokinetics for Treating Pulmonary Nontuberculous Mycobacteria Infection

Melanie Doyle-Eisele, Ph.D. and Director of Life Sciences, and Philip Kuehl, Ph.D, and Director of Scientific Core Laboratories,...
September 16, 2022

Characterization of Dry Powder Inhaler Performance

Dr. Conor Ruzycki, an Aerosol Engineer here at Lovelace Biomedical, has recently published his article titled: Characterization of...
April 22, 2022

Lovelace Biomedical will be Presenting Data on the Non-clinical and Clinical Development Work for HFA-152a at the Upcoming RDD Meeting

Lovelace Biomedical is excited to be presenting data on the non-clinical and clinical development work for HFA-152a at...
August 1, 2021

Hammad Irshad – Using a Degree in Engineering to Make a Difference in Public Health

Hammad has 18 years experience, and focuses on our aerosol development and delivery for novel therapies. Hammad, tell me what...
July 4, 2021

PCR Development, it’s Uses, and Important Research at Lovelace Biomedical, with Bryan Gullick, PhD, Bioanalytical Research Scientist

Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan Gullick, PhD, Bioanalytical Research Scientist Bryan, tell us about PCR in the...
June 1, 2021

Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route

Follow these critical steps on your path to IND application. By Philip J. Kuehl, PhD, Senior Scientist and Director...
January 12, 2021

2020: The Year of the Scientist

2020 was the year of the scientist. In a culture where we primarily celebrate the accomplishments of artists...
January 1, 2021

Lovelace Biomedical Staff Spotlight: Tracylyn Yellowhair – Intra-tracheal (IT) Atomization of IT Liquid Delivery of a Test Article

As translational researchers we’re faced with many challenges in determining the best routes and methods for delivering inhaled...
December 31, 2020

From our Blog: Expert Pre-Clinical Toxicology – There is No Standard Template!

2019’s ACT meeting in Phoenix, AZ was the 40th Annual Meeting and brought some key highlights to the...
October 12, 2020

Are You Getting The Most out of Your Scientific Meeting Attendance?

Thinking about Scientific and professional development. As I reflect upon 2019 and the different trade shows I attended over 2019,...
December 12, 2019

Lovelace Biomedical Staff Spotlight: Janet Benson, Senior Scientist

Today’s staff spotlight belongs to Janet Benson. Janet is one of Lovelace’s longest tenured scientist, with decades of...
September 12, 2019

Post Meeting Thoughts from the North American Cystic Fibrosis Conference (NACFC)

It was reinvigorating to get out from behind the desk, and out of the lab this past weekend...
August 12, 2019

Traumatic Brain Injury – Collaborative Translational Science at Lovelace Biomedical and the Mind Research Network

Traumatic Brain Injury (TBI) is just one of the many areas of scientific study Lovelace Biomedical, along with...
August 1, 2019

Lovelace Biomedical Staff Spotlight: Adam Werts – Veterinary Research Scientist

Today, we put the spotlight on Adam Werts. Adam recently joined Lovelace Biomedical as part of our veterinary...
July 14, 2019

Updating My Business Plan for Competitive Landscape in the CRO Industry – What a Task!

– Jacob McDonald, CSO – Lovelace Biomedical Last summer, I wrote a business plan for Lovelace Biomedical. It...
June 27, 2019

“Beyond Standing Room Only” – Thoughts on the 22nd Annual Meeting of the Society of Gene and Cell Therapy – Dr. Janet Benson

As someone who has watched the ASGCT conference grow fairly steadily over the last 11 years, the growth in...
June 1, 2019

RT-PCR Validations: Square Peg/Round Hole?

Jacob McDonald, CSO – Lovelace Biomedical I set a disclaimer right away, in that I have been called...
May 30, 2019

Lovelace’s Director of Bioanalytical Operations, Larry Mallis to be on hand to present poster at ASMS 2019 annual conference

Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference...
April 29, 2019

Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month

May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and...
April 26, 2019

BIOCHEMISTRY

Biochemistry or biological chemistry is a branch of biology and chemistry involving intense study of different chemical processes...
April 25, 2019

BIOINFORMATICS

Bioinformatics involves in-depth understanding of biological data through strategic development of appropriate software tools. This is an interdisciplinary...
April 24, 2019

CELL BIOLOGY

Cell biology is the intense study of structure, composition, physiology and functioning of cells which is the most...
April 23, 2019

DRUG DESIGN

Preclinical Drug Design or Rational Drug Design is the process of discovering medications. The process of drug design is...
April 22, 2019

MOLECULAR BIOLOGY

Molecular Biology is a branch of biology that understands and analysis the molecular structure, composition and functioning of...
April 19, 2019

PHARMACEUTICS

Pharmaceutics is one of the divisions of pharmacy. It involves dealing with New Chemical Entities or drugs that...
April 18, 2019

SCIENTIFIC RESEARCH

Scientific research is the sequential process of data collection, interpretation, analysis and reporting done in order to make...
April 17, 2019

PRECLINICAL RESEARCH

Preclinical research also known as preclinical study or preclinical development is the phase of research conducted prior to...
April 16, 2019

TOXICOLOGY

Preclinical Toxicology Research – Toxicology is the process of analyzing and understanding the effects of toxic chemical substances when...
April 15, 2019

BIOTECHNOLOGY

Biotechnology is an extensive part of biology involving the development of technically advanced tools and techniques for use...
April 10, 2019

Q & A with Audrey Yarbrough, Lovelace’s Senior Quality Assurance Specialist

Audrey will be attending and presenting at the 35th Annual Society of Quality Assurance Conference in Atlanta, GA...
March 27, 2019

The FDA’s Guidance for Industry on Bioanalytical Method Validation, and us.

My thoughts, post WRIB annual conference – Larry Mallis, Director of Bioanalytical Operations At the recent WRIB meeting,...
March 20, 2019

Who Are You Anyways?

Just a short while back I was in my final stretch of a marathon 31 meetings at the...
March 13, 2019

Not bigger, just better…

Holy cow, it is embarrassing to think that when I was a kid we had that slogan printed...
March 6, 2019

Is There a Place for “Mom & Pop” Toxicology Laboratories?

I always thought that a Mom-and-Pop designation best fit a small bakery or perhaps a hardware store. Sort...
March 5, 2019

Gene Therapy Saved Me – Lovelace Biomedical’s CSO recalls what gene therapy research has done not only for the company, but for himself as well

Gene Therapy Saved Me. I mean, not literally…but certainly from a figurative standpoint. In 2016 I took on...
February 1, 2019

THE PATH TO NEW GENE THERAPY: 7 Steps to IND

An increasing number of pharmaceutical and biotech companies are seeking expert help to navigate investigational gene therapies through preclinical...
January 31, 2019

Putting the Science First – Dr. Jacob McDonald

Our CSO, Dr. Jacob McDonald discusses the evolving CRO market, emerging trends in preclinical research and how Lovelace...
January 10, 2019

Q & A With Dr. Meghan Vermillion, DVM – Who will be speaking at the 2019 ASM Biothreats Conference about Infectious Diseases

Catch Lovelace’s Dr. Meghan Vermillion speaking at the 2019 ASM Biothreats annual conference, which is happening January 29-31. We...
January 4, 2019

Lovelace Expands Veterinary Expertise with New Hires

Top veterinary talent is at the core of preclinical success. And the more complex the study, the more...
January 1, 2019

A Culture of Continuous Improvement: The Lovelace Approach to Quality

The best-run preclinical research programs are just as devoted to strong science and achieving experimental objectives as they...
December 13, 2018

Focus on Infectious Disease: Reducing the Threat of ‘Flu-Imposter’ Adenovirus

It may feel like the flu — and be just as grave of a health threat — but...
December 13, 2018

Lovelace Discovers Novel Approach to Overcome Limitations of Nucleoside Assays

Nucleoside analogues are an essential component of many chemotherapies, anti-bacterial drugs and anti-viral agents. These compounds can play...
April 1, 2018

Lovelace’s Novel Nucleoside LCMS Assay to Be Presented at 12th Workshop on Regulations in Bioanalysis

Increasingly, biopharmaceutical companies are developing nucleoside analogues as chemotherapeutic, anti-bacterial and anti-viral agents. Of the nucleoside analogues in...
March 31, 2018

The Tox Factor: 4 Tips for Drug Sponsors Seeking a Toxicology Partner

Toxicology is often called the “science of safety,” and for good reason. The field is essential in moving...
March 22, 2018

Existing Molecules Find New Calling as Medical Countermeasures

Innovation is percolating around new approaches to treating injuries that result from chemical, biological, radiological and nuclear defense,...
March 13, 2018

Old Drug, New Tricks: Lovelace Paves Fresh Path for Approved Cancer Therapy

The established cancer drug topotecan may hold promise as a more targeted therapy for patients with small-cell lung...
October 9, 2017

Animal Behavioral Management Is Core to Preclinical Success

For preclinical pharmacology and toxicology studies to succeed, it’s essential that investigators and their teams use best practices...
October 3, 2017

The Less Cough, the Better: Lovelace Biomedical, Novartis Research Collaboration Aims to Improve Inhaled Drugs

Inhaled medicines play an essential role in treating respiratory conditions and many other diseases, from pulmonary fibrosis to...
September 28, 2017

Lovelace Research Spotlight: Aerosol-Delivered Gene Therapy for Cystic Fibrosis

In a key study published in Human Gene Therapy Clinical Development, Lovelace Biomedical researchers found that delivering AAV gene...
September 21, 2017

Nose-Only Inhalation of microRNA Shows Promise for Pulmonary Fibrosis

Lovelace Biomedical designed a nose-only inhalation exposure system to evaluate an investigational microRNA-based therapy for pulmonary fibrosis —...
September 14, 2017

Overcoming Preclinical Hurdles in Rare Disease Research

For pharmaceutical and biotech companies, rare diseases present huge market opportunities — but also, potentially daunting development challenges....